TITLE

Correction: Mutations of the Cystic Fibrosis Gene in Patients with Chronic Pancreatitis

AUTHOR(S)
Malats, Núria; Real, Francisco X.
PUB. DATE
May 1999
SOURCE
New England Journal of Medicine;05/20/99, Vol. 340 Issue 20, p1592
SOURCE TYPE
Academic Journal
DOC. TYPE
Letter
ABSTRACT
A letter to the editor is presented in response to the article "Mutations of the cystic fibrosis gene in patients with chronic pancreatitis," by N. Sharer, seen in the September 3, 1999 issue.
ACCESSION #
24900489

 

Related Articles

  • Correction: Mutations of the Cystic Fibrosis Gene in Patients with Chronic Pancreatitis. Sharer, Nicholas M.; Schwartz, Martin J. // New England Journal of Medicine;05/20/99, Vol. 340 Issue 20, p1592 

    A reply by the author is given in response to a letter to the editor on the article "Mutations of the cystic fibrosis gene in patients with chronic pancreatitis," seen in the September 3, 1999 issue.

  • Genetic Modifiers in Cystic Fibrosis. Stanke, Frauke; T�mmler, Burkhard; Becker, Tim // New England Journal of Medicine;1/5/2006, Vol. 354 Issue 1, p88 

    A letter to the editor is presented in response to a study on genetic modifiers of lung disease in cystic fibrosis by researcher Mitchell Drumm and colleagues in the October 6, 2005 issue.

  • Hypertonic Saline for Cystic Fibrosis. Aziz, Imran; Kastelik, Jack A. // New England Journal of Medicine;4/27/2006, Vol. 354 Issue 17, p1848 

    A letter to the editor is presented in response to an article on the use of hypertonic saline for the treatment of cystic fibrosis, in the January 19, 2006 issue.

  • Hypertonic Saline for Cystic Fibrosis. Kuver, Rahul; Lee, Sum P. // New England Journal of Medicine;4/27/2006, Vol. 354 Issue 17, p1848 

    A letter to the editor is presented in response to an article on the use of hypertonic saline for the treatment of cystic fibrosis, in a previous issue.

  • Hypertonic Saline for Cystic Fibrosis. Bye, Peter T.P.; Elkins, Mark R. // New England Journal of Medicine;4/27/2006, Vol. 354 Issue 17, p1848 

    A response from Peter T.P. Bye and Mark R. Elkins to several letters to the editor on the use of hypertonic saline for the treatment of cystic fibrosis is presented.

  • Hypertonic Saline for Cystic Fibrosis. Donaldson, Scott H.; Tarran, Robert; Boucher, Richard C. // New England Journal of Medicine;4/27/2006, Vol. 354 Issue 17, p1848 

    A response from Scott H. Donaldson and colleagues to several letters to the editor on the use of hypertonic saline and corticosteroids for the treatment of cystic fibrosis is presented.

  • Gentamicin and CFTR. Kida, Yujiro // New England Journal of Medicine;12/25/2003, Vol. 349 Issue 26, p2570 

    A letter to the editor is presented in response to the article "Gentamicin-Induced Correction of CFTR Function in Patients with Cystic Fibrosis and CFTR Stop Mutations" in the October 9, 2003 issue.

  • Gastrointestinal Cancer and the Cystic Fibrosis Gene. Neglia, Joseph P.; FitzSimmons, Stacey C.; Lowenfels, Albert B. // New England Journal of Medicine;7/13/95, Vol. 333 Issue 2, p129 

    A response by Joseph P. Neglia, Stacey C. FitzSimmons and Albert B. Lowenfels to a letter to the editor about their article on the cystic fibrosis gene in a previous issue is presented.

  • Variant Cystic Fibrosis Phenotypes in the Absence of CFTR Mutations. Couper, Richard T.L. // New England Journal of Medicine;12/5/2002, Vol. 347 Issue 23, p1892 

    A letter to the editor is presented in response to an article focusing on variant cystic fibrosis phenotypes by J.D. Groman and others in the August 8, 2002 issue.

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sign out of this library

Other Topics